The growing era of personalised medicine

Sep 26, 2022
  • Our projects
  • All news

Application to the intensive care unit (ICU) setting.

eapm03-155154.jpg

With the recent scientific advances, personalised medicine is witnessing a breakthrough in numerous realms, from cancer and gene therapy to the intensive care unit (ICU) setting, to name a few.

In this context, AxTalis brought the world's most renowned experts together to discuss the options for personalised medicine in the intensive care unit (ICU) setting for one of our clients. The process involved in-depth literature research, summaries for the opinion leaders, individual discussions and finally, a consensus meeting with the experts. Clear recommendations were formulated, and an outline for a manuscript was developed. Our client leveraged this to build further their close collaboration with and long-term commitment to the clinicians.